AI assistant
NORTHROP GRUMMAN CORP /DE/ — Director's Dealing 2020
Feb 15, 2020
29899_dirs_2020-02-14_784d0910-7949-466d-be09-a8a5b962404b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NORTHROP GRUMMAN CORP /DE/ (NOC)
CIK: 0001133421
Period of Report: 2020-02-12
Reporting Person: Hardesty Michael A (Corp VP, Controller & CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-12 | Common Stock | M | 3572.0000 | $0.0000 | Acquired | 8378.2000 | Direct |
| 2020-02-12 | Common Stock | F | 1215.0000 | $0.0000 | Disposed | 7163.2000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-12 | Restricted Performance Stock Rights | $ | A | 3172.0000 | Acquired | Common Stock (3172.0000) | Direct | |
| 2020-02-12 | Restricted Performance Stock Rights | $ | M | 3572.0000 | Disposed | Common Stock (3572.0000) | Direct | |
| 2020-02-12 | Restricted Stock Rights | $ | A | 594.0000 | Acquired | Common Stock (594.0000) | Direct |
Footnotes
F1: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 200% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020.
F2: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e)
F3: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
F4: The RPSRs acquired include (i) 1,786 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 200% of the target award and (ii) 1,386 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22.
F5: Total amount includes 3,572 vested RPSRs granted under the LTISP on 2/17/17 with a measurement period ended on 12/31/19; 1,386 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 1,788 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 1,475 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20.
F6: Total amount includes 1,386 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 1,788 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 1,475 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20.
F7: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23.
F8: Total amount includes 594 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 766 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 632 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; and 765 RSRs granted under the LTISP on 2/17/17 that will vest on 2/18/20.